AI for a task that should be done by a physician rather than using it for other burdens that are less worthy than expressing care for patients,” authors of an editorial wrote.

Results showed only 6 products had elevated levels of benzene and more than 90% of tested products had undetectable or extremely low levels of benzene. Certain over-the-counter (OTC) acne products ...

HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at ...

The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, accord ...

"The most effective health-promoting solution would be to effectively end food insecurity through social policies and an augmented social safety net." ...

HealthDay News — The majority of people are unaware that the human papillomavirus (HPV) is more common among men and is associated with rising rates of cancers that directly impact men, according to ...

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...

The survey revealed that 18% of young adults aged 18 to 29 years needed to borrow money to pay health care costs. Adults aged 30 to 49 years reported similar rates. However, only 9 and 2% of Americans ...

Vepdegestrant is a novel proteolysis targeting chimera protein degrader designed to target and degrade the estrogen receptor.

Johnson & Johnson is ending the phase 3 VENTURA clinical development program evaluating aticaprant, a selective kappa receptor antagonist, as an adjunctive treatment for major depressive disorder (MDD ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...